Kenvue Share Price

Kenvue Share Price

NYSE: KVUE | Consumer Defensive
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

Kenvue Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Kenvue Share Price Chart

$0.00$0.00
L
Show Current Price
H

Kenvue Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
21.96
Dividend Yield
4.30%
EPS (TTM)
$0.88
Revenue (TTM)
$15.12B
Return On Equity (TTM)
16.63%
Profit Margin
9.72%
Debt to Equity
0.81
Quarterly Earnings Growth YoY
30.30%

Kenvue Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3780.00$3909.00$3955.00$3886.00
Net Profit$330.00$474.00$456.00$430.00
Net Profit Margin8.73%12.13%11.53%11.07%
Income ChangeN/A43.64%-3.80%-5.70%

Kenvue Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$15.44$15.46$15.12
Net Profit$1.66$1.03$1.47
Net Profit Margin10.75%6.66%9.72%
Income ChangeN/A-37.95%42.72%

Kenvue Balance Sheet

All figures in USD Billion

Particulars202520242023
Non Current Assets21.3820.0821.71
Current Assets5.75.536.14
Total Assets27.0825.627.85
Non Current Liabilities10.3710.1911.16
Current Liabilities5.955.745.48
Total Liabilities16.3115.9316.64
Shareholders' Equity10.779.6711.21

Kenvue Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating2,197.01,769.03,168.0
Investing-436.0-425.0-488.0
Financing-1,837.0-1,565.0-2,527.0

Corporate Actions

Dividend
Ex-date: 21 Sep 2026

Dividend
Ex-date: 12 Aug 2026

Dividend
Ex-date: 13 May 2026

Dividend
Ex-date: 11 Feb 2026

Dividend
Ex-date: 12 Nov 2025

Dividend
Ex-date: 13 Aug 2025

Dividend
Ex-date: 14 May 2025

Dividend
Ex-date: 12 Feb 2025

Dividend
Ex-date: 13 Nov 2024

Dividend
Ex-date: 14 Aug 2024

Dividend
Ex-date: 07 May 2024

Dividend
Ex-date: 13 Feb 2024

About Kenvue

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Kenvue Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Kenvue Share Price FAQs